Scientists from the University of Oregon Science and Health have created a new drug KBU2046, blocking the spread of cancer.

Researchers published an article in the journal Nature Communications.

The new medicine stops the development of four types of oncology - the dairy and prostate gland, the colon and lungs. Scientists conducted experiments on rodents with human prostate and breast cancer, as well as intestine and lung cancer.

The experiment showed that KBU2046 suppressed metastases and reduced bone destruction.

Side effects and toxicity were minimized.

The principle of the drug is based on a change in the phosphorylation of HSP90 protein?. According to the head of the study, Dr. Raymond Bergan, the drug binds to the protein and stops the movement of cells.

There is no side effect on the protein. Scientists believe that their medicine with an early diagnosis can stop the reproduction of cancer cells and save.

sundaynews. info.

Keywords:.